AbCellera Biologics Inc. financial data

Symbol
ABCL on Nasdaq
Location
150 W 4 Th Avenue, Vancouver, British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.01K % +20.4%
Debt-to-equity 32.1 % +12.9%
Return On Equity -15.9 % -18.7%
Return On Assets -12.1 % -15.4%
Operating Margin -848 % -4.04%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 299M shares +1.41%
Common Stock, Shares, Outstanding 296M shares +1.7%
Entity Public Float 671M USD -54.2%
Common Stock, Value, Issued 792M USD +2.82%
Weighted Average Number of Shares Outstanding, Basic 299M shares +1.46%
Weighted Average Number of Shares Outstanding, Diluted 299M shares +1.46%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 32.9M USD -0.54%
Research and Development Expense 169M USD +1.2%
Selling and Marketing Expense 12.1M USD -7.19%
General and Administrative Expense 70.4M USD +3.66%
Operating Income (Loss) -279M USD -3.48%
Nonoperating Income (Expense) 79.9M USD -11.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -199M USD -11.2%
Income Tax Expense (Benefit) -33.1M USD -29.8%
Net Income (Loss) Attributable to Parent -166M USD -8.07%
Earnings Per Share, Basic 0 USD/shares -3.77%
Earnings Per Share, Diluted 0 USD/shares -3.77%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 92.4M USD -37.7%
Cash, Cash Equivalents, and Short-term Investments 553M USD -17.5%
Other Assets, Current 117M USD +191%
Assets, Current 742M USD -3.81%
Property, Plant and Equipment, Net 277M USD +38.2%
Operating Lease, Right-of-Use Asset 137M USD +95.2%
Intangible Assets, Net (Excluding Goodwill) 40.3M USD -53%
Goodwill 47.8M USD 0%
Other Assets, Noncurrent 57.5M USD -48.9%
Assets 1.4B USD -0.74%
Employee-related Liabilities, Current 4.97M USD +14%
Contract with Customer, Liability, Current 16.9M USD +165%
Liabilities, Current 67M USD -4.77%
Contract with Customer, Liability, Noncurrent 11.6M USD +46%
Deferred Income Tax Liabilities, Net 10.1M USD -53.8%
Operating Lease, Liability, Noncurrent 137M USD +106%
Other Liabilities, Noncurrent 1.56M USD -75.4%
Liabilities 395M USD +31%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.66M USD -28.2%
Retained Earnings (Accumulated Deficit) 36.6M USD -81.9%
Stockholders' Equity Attributable to Parent 1.01B USD -9.35%
Liabilities and Equity 1.4B USD -0.74%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.6M USD +72.3%
Net Cash Provided by (Used in) Financing Activities 5.97M USD +111%
Net Cash Provided by (Used in) Investing Activities 7.94M USD -73.5%
Common Stock, Shares, Issued 296M shares +1.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.94M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 117M USD -32.2%
Deferred Tax Assets, Valuation Allowance 49.9M USD +47.5%
Deferred Tax Assets, Gross 104M USD +27.5%
Operating Lease, Liability 65.4M USD -15.5%
Depreciation 14.9M USD +10.7%
Payments to Acquire Property, Plant, and Equipment 10.6M USD -55.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -166M USD -8.32%
Property, Plant and Equipment, Gross 304M USD +40.6%
Operating Lease, Liability, Current 4.9M USD -12.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.88M USD -18.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.82M USD -20.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.78M USD -16.2%
Deferred Tax Assets, Operating Loss Carryforwards 15.6M USD +115%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.82M USD -5.23%
Amortization of Intangible Assets 922K USD -45.4%
Share-based Payment Arrangement, Expense 61.4M USD -9.06%